Literature DB >> 15886158

Overcoming economic barriers to the optimal use of vaccines.

Tracy A Lieu1, Thomas G McGuire, Alan R Hinman.   

Abstract

Vaccines are among the most cost-effective interventions in health care, but economic factors may interfere with their optimal development and delivery in both industrialized and developing countries. For the United States, making the best use of available vaccines will require increasing the financing for vaccines via the public and private systems. For developing countries, innovative and promising approaches include pull mechanisms to establish predictable demand and push mechanisms such as targeted development programs. Partnerships between philanthropy and public resources have made progress in addressing gaps in vaccine financing and development for developing countries, but much remains to be done.

Mesh:

Substances:

Year:  2005        PMID: 15886158     DOI: 10.1377/hlthaff.24.3.666

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  8 in total

Review 1.  Pricing of new vaccines.

Authors:  Bruce Y Lee; Sarah M McGlone
Journal:  Hum Vaccin       Date:  2010-08

2.  Estimating utility values for vesicoureteral reflux in the general public using an online tool.

Authors:  Jessica C Lloyd; Talitha Yen; Ricardo Pietrobon; John S Wiener; Sherry S Ross; Paul J Kokorowski; Caleb P Nelson; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2014-04-04       Impact factor: 1.830

3.  Utility scores for vesicoureteral reflux and anti-reflux surgery.

Authors:  Caleb P Nelson; Jonathan C Routh; Tanya Logvinenko; Ilina Rosoklija; Paul J Kokorowski; Lisa A Prosser; Mark A Schuster
Journal:  J Pediatr Urol       Date:  2015-04-30       Impact factor: 1.830

Review 4.  Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.

Authors:  Bruce Y Lee; Donald S Burke
Journal:  Vaccine       Date:  2009-09-25       Impact factor: 3.641

Review 5.  Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.

Authors:  Lisa A Prosser; James K Hammitt; Ron Keren
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

7.  Health benefits, risks, and cost-effectiveness of influenza vaccination of children.

Authors:  Lisa A Prosser; Carolyn Buxton Bridges; Timothy M Uyeki; Virginia L Hinrichsen; Martin I Meltzer; Noelle-Angelique M Molinari; Benjamin Schwartz; William W Thompson; Keiji Fukuda; Tracy A Lieu
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

8.  Vaccination: the cornerstone of an efficient healthcare system.

Authors:  Vanessa Rémy; York Zöllner; Ulrike Heckmann
Journal:  J Mark Access Health Policy       Date:  2015-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.